SPECTRE A single arm Phase II study to test if adding statins to hormone treatment will result in better cancer control in patients with hormone resistant prostate cancer.

Registry ID

EUCTR2015-003720-32

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

NHS Greater Glasgow and Clyde

Start date

2016-04-08

Completion date

2019-08-01

Last update

2026-08-16

Conditions

• Castration Resistant Prostate Cancer

Summary

To explore the impact of atorvastatin on androgen receptor signalling in castration-resistant prostate cancer.

Locations

• , , UK

Related clinical trials

• Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

View on source registry